Relationship between female dyslipidemia and polymorphism of suppressor of cytokine signaling-3 in Xinjiang Uygur population.
- Author:
Jing MENG
1
;
Nan-fang LI
2
;
Xiao-guang YAO
2
;
Liang SHAO
2
;
Ling ZHOU
2
;
Abdurmy ARIKIN
2
;
Jing-jing ZHANG
2
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Asian Continental Ancestry Group; genetics; China; epidemiology; Dyslipidemias; ethnology; genetics; Female; Humans; Male; Middle Aged; Polymorphism, Genetic; Prevalence; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; genetics
- From: Acta Academiae Medicinae Sinicae 2014;36(1):5-11
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore whether the polymorphism of suppressor of cytokine signaling-3 (SOCS-3) and dyslipidemia are correlated in Uygur females.
METHODSA total of 1379 Uygur females from Xinjiang Uygur Autonomous Region were enrolled in this study. Three single nucleotide polymorphisms (SNPs), namely rs12953258, rs4969168, and rs9914220, were analyzed after being genotyped.
RESULTSOf these three SNPs, the frequency distribution of rs12953258 sites was found to be significantly different between dyslipidemia group and normal group (P=0.032). The frequency distribution of rs12953258 sites between the high-density lipoprotein-cholesterol (HDL-C) abnormal group and normal group also showed significant difference (P=0.029). Logistic regression analysis showed that the genotype AA of rs12953258 was a risk factor for dyslipidemia among the Uygur females [CC vs. AA:OR=3.271,95%CI(1.092-9.797), P=0.034]. The genotype AA of rs12953258 might be related to the decreased high HDL-C and increased trigleceride, whereas the genotype AA coupled with abnormal body mass index (BMI) were more likely to be linked with the higher prevalence of dyslipidemia in Uygur females.
CONCLUSIONSThe polymorphism of SOCS-3 is correlated to the dyslipidemia in Uygur females in Xinjiang. Carriers of Genotype AA of rs12953258 coupled with abnormal BMI are more susceptible to dyslipidemia.